Clinical Trials
11
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:9
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Phase 1
9 (90.0%)Phase 2
1 (10.0%)Role of UC-MSC and CM to Inhibit Vision Loss in Retinitis Pigmentosa Phase I/II
Phase 2
Not yet recruiting
- Conditions
- Retinitis Pigmentosa
- Interventions
- Biological: 1.5 x 10^6 UC-MSC + CMBiological: 5 x 10^6 UC-MSC + CM
- First Posted Date
- 2023-06-18
- Last Posted Date
- 2025-07-10
- Lead Sponsor
- PT. Prodia Stem Cell Indonesia
- Target Recruit Count
- 30
- Registration Number
- NCT05909488
- Locations
- 🇮🇩
RSUP Dr. Sardjito, Yogyakarta, DI Yogyakarta, Indonesia
Long-term Safety of UC-MSC Transplantation in Patients With Retinitis Pigmentosa
- Conditions
- Retinitis Pigmentosa
- First Posted Date
- 2023-03-27
- Last Posted Date
- 2023-06-13
- Lead Sponsor
- PT. Prodia Stem Cell Indonesia
- Target Recruit Count
- 18
- Registration Number
- NCT05786287
- Locations
- 🇮🇩
Jakarta Eye Center Hospital, Jakarta, DKI Jakarta, Indonesia
🇮🇩Sardjito Hospital, Yogyakarta, Special Region, Indonesia
Stem Cells and Secretomes for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.
Phase 1
Recruiting
- Conditions
- Polycystic Ovary Syndrome
- First Posted Date
- 2022-03-15
- Last Posted Date
- 2022-09-26
- Lead Sponsor
- PT. Prodia Stem Cell Indonesia
- Target Recruit Count
- 40
- Registration Number
- NCT05279768
- Locations
- 🇮🇩
PT Prodia StemCell Indonesia, Jakarta, Indonesia
Autologous Dendritic Cells and Allogenic Dendritic Secretomes for Patients With Advanced Nasopharyngeal Cancer
Phase 1
Recruiting
- Conditions
- Nasopharyngeal Cancer
- First Posted Date
- 2022-03-02
- Last Posted Date
- 2022-09-26
- Lead Sponsor
- PT. Prodia Stem Cell Indonesia
- Target Recruit Count
- 15
- Registration Number
- NCT05261750
- Locations
- 🇮🇩
PT Prodia StemCell Indonesia, Jakarta, Indonesia
Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Acute Stroke Infarct
Phase 1
Recruiting
- Conditions
- Ischemic Stroke
- First Posted Date
- 2021-08-17
- Last Posted Date
- 2022-09-26
- Lead Sponsor
- PT. Prodia Stem Cell Indonesia
- Target Recruit Count
- 15
- Registration Number
- NCT05008588
- Locations
- 🇮🇩
Gatot Soebroto Hospital, Jakarta Pusat, DKI Jakarta, Indonesia
🇮🇩PT Prodia StemCell Indonesia, Jakarta, Indonesia
- Prev
- 1
- 2
- 3
- Next
News
No news found